This revealed tumor‐specific potential markers, several of which have been previously implicated in tumor biology (e.g., F2RL2 in gynecological cancers, DHCR24 and RAG1 in thymic carcinoma, PTGDS in cholangiocarcinoma). This evidence concerns the gene F2RL2 and cholangiocarcinoma.